Veri Medtech Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2011	FY 2010	FY 2009
Period Ending	Mar '12 Mar 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
Net Income	-0.35	-0.35	-0.04	-0.08
Depreciation & Amortization	0	0	-	-
Other Operating Activities	-0	-0	-	-
Change in Accounts Receivable	0.01	0	0.01	0.23
Change in Inventory	-0	-0	-0.01	-
Change in Accounts Payable	-0.01	0	0	-0.01
Change in Other Net Operating Assets	-0	-0	0.04	0.04
Operating Cash Flow	-0.35	-0.34	0.01	0.18
Operating Cash Flow Growth	-	-	-96.48%	-
Investment in Securities	-0.28	-0.28	-0.53	-0.21
Investing Cash Flow	0.03	0.03	-0.53	-0.52
Long-Term Debt Issued	-	-	0.01	0.18
Long-Term Debt Repaid	-	-0.18	-	-
Net Debt Issued (Repaid)	-0.18	-0.18	0.01	0.18
Issuance of Common Stock	0.5	0.5	0.52	0.13
Financing Cash Flow	0.32	0.32	0.53	0.31
Net Cash Flow	-0.01	0.01	0.01	-0.03
Levered Free Cash Flow	-0.03	-0.02	-	-
Unlevered Free Cash Flow	-0.03	-0.02	-	-
Change in Net Working Capital	0	-0.01	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.